Bastian Keck
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
A Randomized Trial of an App-Based Therapeutic for Lower Urinary Tract Symptoms.
Journal: NEJM evidence
Published: March 25, 2025
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.
Journal: Life (Basel, Switzerland)
Published: June 08, 2021
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer.
Journal: Cancer management and research
Published: May 06, 2021
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer.
Journal: Urologic oncology
Published: April 26, 2021
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy.
Journal: Journal for immunotherapy of cancer
Published: April 21, 2020
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy.
Journal: Journal of clinical medicine
Published: March 04, 2020
Metastatic risk stratification of clear cell renal cell carcinoma patients based on genomic aberrations.
Journal: Genes, chromosomes & cancer
Published: January 03, 2019
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts.
Journal: Translational oncology
Published: December 28, 2018
The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes.
Journal: Cancer immunology research
Published: October 22, 2018
Last Updated: 09/26/2026